Nitric oxide and bone

Immunology

Volumn 103, Issue 3, 2001, Pages 255-261

  Van't Hof, Rob J ^a   Ralston, Stuart H ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOKINE; ESTROGEN; FREE RADICAL; GAMMA INTERFERON; INTERLEUKIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN;

BONE CELL; BONE DISEASE; BONE TURNOVER; CELL FUNCTION; ENZYME ACTIVATION; HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE DEVELOPMENT; BONE RESORPTION; ESTROGENS; HUMANS; NITRIC OXIDE;

EID: 0034931341     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01261.x     Document Type: Review

References (88)

1. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
2. The L-arginine nitric oxide pathway
3. Bone resorption by osteoclasts
4. Formation of multinucleated cells that respond to osteotropic hormones in long-term human marrow cultures
5. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone
6. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
7. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation
8. Bone loss. Factors that regulate osteoclast differentiation: An update
9. Stomach NO synthesis
10. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor
11. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
12. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (nos3) gene
13. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme
14. The Akt kinase signals directly to endothelial nitric oxide synthase
15. Organisation of the bovine gene encoding the endothelial nitric oxide synthase
16. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress
17. Estrogen increases endothelial nitric oxide by a receptor- mediated system
18. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter
19. On the expression of nitric oxide synthase by human macrophages. Why no NO?
20. Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: Autocrine NO mediates Ca2+-inhibited bone resorption
21. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase
22. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
23. Nitric oxide production in cells derived from the human joint
24. The role of nitric oxide in IL-1 induced inhibition of proteoglycan synthesis in human articular cartilage
25. Mechanisms of cytokine induced bone resorption: Role of nitric oxide, cyclic guanosine monophosphate and prostaglandins
26. The L-arginine nitric oxide pathway
27. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from arginine
28. Nitric oxide-stimulated guanine nucleotide exchange on p21ras
29. Differential activation of mitogen-activated protein kinases by nitric oxide-related species
30. A molecular redox switch on p21 (ras). Structural basis for the nitric oxide-p21 (ras) interaction
31. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds
32. Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP
33. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent
34. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms
35. Expression of nitric oxide synthase isoforms in bone and bone cell cultures
36. Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells
37. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localisation with NADPH diphorase but not with soluble guanylate cyclase and novel paraneural functions for signal transduction
38. Nitric oxide synthase expression in bone cells
39. Developmental regulation of nitric oxide synthase expression in rat skeletal bone
40. Inducible production of nitric oxide in osteoblast like cells and in fetal bone explants is associated with supression of osteoclastic bone resorption
41. Nitric oxide: A cytokine-induced regulator of bone resorption
42. Cytokine induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity
43. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis
44. Requirement of the inducible nitric oxide synthase pathway for 1L-1- induced osteoclastic bone resorption
45. Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP
46. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity
47. Inhibition of cathepsin K by nitric oxide donors: Evidence for the formation of mixed disulfides and a sulfenic acid
48. Expression and functional role of nitric oxide synthase in osteoblast-like cells
49. Nitric oxide stimulates osteoblast replication and development
50. Nitric oxide accelerates the ascorbic acid-induced osteoblastic differentiation of mouse stromal ST2 cells by stimulating the production of prostaglandin E (2)
51. Defective bone formation and anabolic responses to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide sythase
52. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation reduced bone volume, defects in osteoblast maturation activity
53. Cytokines induce nitric oxide production in mouse osteoblasts
54. Nitric oxide acts in conjunction with pro-inflammatory cytokines to promote cell death in osteoblasts
55. Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1
56. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease
57. Bone turnover in non-steroid treated rheumatoid arthritis
58. Inflammation mediated osteopaenia in the rat: A new animal model for pathological loss of bone mass
59. The effects of growth and ovariectomy on bone mineral density in inducible nitric oxide synthase deficient mice
60. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells
61. Nitric oxide donor alleviates ovariectomy-induced bone loss
62. Restoration of ovariectomy-induced osteopenia by nitroglycerin
63. Sensitivity of osteocytes to biomechanical stress in vitro
64. Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent
65. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes
66. Fluid flow stimulates rapid and continuous release of nitric oxide in osteoblasts
67. Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate: Creatinine ratio
68. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone
69. Increased nitric oxide levels in patients with rheumatoid arthritis
70. Nitric-oxide mediates interleukin-l-induced matrix degradation and basic fibroblast growth-factor release in cultured rabbit articular chondrocytes - A possible mechanism of pathological neovascularization in arthritis
71. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients
72. Detection of nitric-oxide complexed in s-nitrosoproteins in rheumatoid-arthritis (ra)
73. Protection against peroxynitrite dependent tyrosine nitration and alpha (1)-antiproteinase inactivation by some antiinflammatory drugs and by the antibiotic tetracycline
74. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients
75. Immunolocalisation of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis
76. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides
77. Nitric oxide synthesis and its regulation by rabbit synoviocytes
78. Apoptosis in rheumatoid arthritis synovium
79. Nitric oxide is a mediator of apoptosis in the rheumatoid joint
80. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways
81. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium
82. Chondrocyte apoptosis induced by nitric oxide
83. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4
84. N-Monomethyl arginine, an inhibitor of nitric oxide synthase,suppresses the development of adjuvant arthritis in rats
85. Supression of arthritis by an inhibitor of nitric oxide synthase
86. Modulation of adjuvant arthritis by endogenous nitric oxide
87. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis